 |
2′,3′,5′-tri-o-acetyluridine |
|---|---|
| Trade Name | |
| Orphan Indication | Mitochondrial disease |
| USA Market Approval | USA |
| USA Designation Date | 2003-01-13 00:00:00 |
| Sponsor | Repligen Corporation;41 Seyon Street, Building 1, Suite 100;Waltham, Massachusetts, 02453 |
| |
2′,3′,5′-tri-o-acetyluridine |
|---|---|
| Trade Name | |
| Orphan Indication | Mitochondrial disease |
| USA Market Approval | USA |
| USA Designation Date | 2003-01-13 00:00:00 |
| Sponsor | Repligen Corporation;41 Seyon Street, Building 1, Suite 100;Waltham, Massachusetts, 02453 |